Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin

被引：0
|
作者：
Belle, Ludovic [1 ]
Binsfeld, Marilene [1 ]
Dubois, Sophie [1 ]
Hannon, Muriel [1 ]
Caers, Jo [1 ]
Briquet, Alexandra [1 ]
Menten, Catherine [1 ]
Beguin, Yves [1 ]
Humblet, Stephanie [1 ]
Baron, Frederic [1 ]
机构：
[1] Univ Liege, GIGA 13, Liege, Belgium
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2012.11.476
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
418
引用
收藏
页码：S317 / S318
页数：2
相关论文
共 50 条
  • [21] Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease
    Johnston, LJ
    Brown, J
    Shizuru, JA
    Stockerl-Goldstein, KE
    Stuart, MJ
    Blume, KG
    Negrin, RS
    Chao, NJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (01) : 47 - 55
  • [22] The effects of mesenchymal stem cells in a murine sclerodermatous model of graft-versus-host disease
    Lim, Ji-Young
    Ryu, Da-Bin
    Lee, Sung-Eun
    Oh, Il-Hoan
    Min, Chang-Ki
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [23] Sclerodermatous chronic graft-versus-host disease: A report of 4 pediatric cases
    Devereux, Clare
    Tolland, Julia
    Bingham, Ann
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB154 - AB154
  • [24] Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease
    Hurabielle, C.
    de Fontbrune, F. Sicre
    Moins-Teisserenc, H.
    Robin, M.
    Jachiet, M.
    Coman, T.
    Dhedin, N.
    Cassius, C.
    Chasset, F.
    de Masson, A.
    Michonneau, D.
    Bagot, M.
    Bergeron, A.
    Socie, G.
    de Latour, R. Peffault
    Bouaziz, J-D
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E206 - E208
  • [25] Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective
    Moles-Poveda, P.
    Montesinos, P.
    Sanz-Caballer, J.
    de Unamuno, B.
    Pinana, J. L.
    Sahuquillo, A.
    Botella-Estrada, R.
    ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (03): : 241 - 247
  • [26] Electron-microscopic study of sclerodermatous chronic graft-versus-host disease
    Tabata, H
    Yamakage, A
    Yamazaki, S
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1996, 35 (12) : 862 - 866
  • [27] Sclerodermatous chronic graft-versus-host disease - A report of four pediatric cases
    Tolland, Julia P.
    Devereux, Clare
    Jones, Frank C. G.
    Bingham, E. Ann
    PEDIATRIC DERMATOLOGY, 2008, 25 (02) : 240 - 244
  • [28] Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease
    Namdaroglu, S.
    Iskender, D.
    Dal, M. S.
    Cakar, M. K.
    Tekgunduz, E.
    Altuntas, F.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2019, 27 (01): : 12 - 18
  • [29] Lichen sclerosus et atrophicus in sclerodermatous chronic graft-versus-host disease
    Córdoba, S
    Vargas, E
    Fraga, J
    Aragüés, M
    Fernández-Herrera, J
    García-Díez, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (09) : 708 - 711
  • [30] Anti-fractalkine monoclonal antibody therapy ameliorates murine sclerodermatous chronic graft-versus-host disease
    Utsunomiya, A.
    Luong, V. Huy
    Chino, T.
    Oyama, N.
    Matsushita, T.
    Ishii, N.
    Ogasawara, H.
    Toshio, I.
    Hasegawa, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S149 - S149
12345